Huntington's disease and the striatal medium spiny neuron: cell-autonomous and non-cell-autonomous mechanisms of disease
about
AAV-dominant negative tumor necrosis factor (DN-TNF) gene transfer to the striatum does not rescue medium spiny neurons in the YAC128 mouse model of Huntington's diseaseInduction of DARPP-32 by brain-derived neurotrophic factor in striatal neurons in vitro is modified by histone deacetylase inhibitors and Nab2Characterization of ST14A Cells for Studying Modulation of Voltage-Gated Calcium Channels.Dissecting the Molecular Mechanisms of Neurodegenerative Diseases through Network BiologyWheel running alters patterns of uncontrollable stress-induced cfos mRNA expression in rat dorsal striatum direct and indirect pathways: A possible role for plasticity in adenosine receptorsDeep white matter in Huntington's diseasePhosphorylation of mutant huntingtin at serine 116 modulates neuronal toxicity.Differential CaMKII regulation by voltage-gated calcium channels in the striatum.αB-Crystallin overexpression in astrocytes modulates the phenotype of the BACHD mouse model of Huntington's diseaseBehavioral and transcriptome alterations in male and female mice with postnatal deletion of TrkB in dorsal striatal medium spiny neurons.Subsite awareness in neuropathology evaluation of National Toxicology Program (NTP) studies: a review of select neuroanatomical structures with their functional significance in rodentsNitric Oxide Production in the Striatum and Cerebellum of a Rat Model of Preterm Global Perinatal Asphyxia.Cellular maintenance of nuclear protein homeostasisStem cell therapy and cellular engineering for treatment of neuronal dysfunction in Huntington's disease.Metabotropic glutamate receptor 5 as a potential therapeutic target in Huntington's disease.Discovery of Therapeutic Approaches for Polyglutamine Diseases: A Summary of Recent Efforts.Selective Vulnerability of Striatal D2 versus D1 Dopamine Receptor-Expressing Medium Spiny Neurons in HIV-1 Tat Transgenic Male Mice.Genomic Analysis Reveals Disruption of Striatal Neuronal Development and Therapeutic Targets in Human Huntington's Disease Neural Stem Cells.Transneuronal propagation of mutant huntingtin contributes to non-cell autonomous pathology in neurons.Voluntary saccade inhibition deficits correlate with extended white-matter cortico-basal atrophy in Huntington's disease.Editorial: Mapping Psychopathology with fMRI and Effective Connectivity Analysis.Animal models of neurological disorders.The Corticospinal Tract in Huntington's Disease.Combined lesions of direct and indirect basal ganglia pathways but not changes in dopamine levels explain learning deficits in patients with Huntington's disease.Early pridopidine treatment improves behavioral and transcriptional deficits in YAC128 Huntington disease mice.Disease-modifying effects of ganglioside GM1 in Huntington's disease models.A Cell Type-Specific Expression Signature Predicts Haploinsufficient Autism-Susceptibility Genes.A model-based analysis of physiological properties of the striatal medium spiny neuron.Cell-specific deletion of PGC-1α from medium spiny neurons causes transcriptional alterations and age-related motor impairment.A novel ex vivo Huntington's disease model for studying GABAergic neurons and cell grafts by laser microdissection.Reactive Neuroblastosis in Huntington's Disease: A Putative Therapeutic Target for Striatal Regeneration in the Adult Brain.Environment-dependent striatal gene expression in the BACHD rat model for Huntington disease.hPSC-Derived Striatal Cells Generated Using a Scalable 3D Hydrogel Promote Recovery in a Huntington Disease Mouse Model.The adjustment of γ-aminobutyric acidA tonic subunits in Huntington's disease: from transcription to translation to synaptic levels into the neostriatum.The Tiny for the Biggest Answers in Huntington's Disease
P2860
Q27334472-F0DAF34B-26AB-48C2-8D40-1001609FF2EFQ28534553-D7E9FA7B-F0FF-4BD5-B1E8-D92052E3E8ABQ30379878-9CFC63F8-5404-4A60-AD49-0A820FFDAAECQ33734563-BFFFBC61-1657-48C2-A700-D29E1A26A879Q34337032-9E41179F-CA59-423C-BD8B-427C0D4AC031Q34394979-7A378139-9898-4D0C-AD2E-4754E35DBBD8Q35088655-BD3CAEF5-6250-4ABD-8733-13AE6A03BDF2Q36122543-DE2A7F22-422C-418C-80A3-5C2D584D2496Q37178561-6943BEFB-323A-4A8B-A38B-89DF23C8E511Q37434203-D52D5D08-9BBF-465D-A121-C22D5DAA0376Q37662764-B288CD35-BADD-457F-88B4-E96418523AD6Q37714572-E7E34E07-21A8-4668-8CA5-50AB5FFA5536Q38168709-79353F1E-1576-4E8B-8366-5680CCE93A33Q38211724-F11F2838-74C5-46EB-8E0F-CE45C3D04FFCQ38239515-8C52DCE8-34F3-4948-BD23-F620ABFAFB20Q38792714-94DA94AA-D9AC-46A2-B9EB-6D829702ED4EQ38803243-E8FA6D82-0C40-42FB-A50D-1530EC94B929Q38813105-33348A68-F13C-438C-A9F1-0D62F3DE2615Q38975954-4A570E4A-A1A8-414D-B6E4-E952085D16ECQ42176734-6DC9DF1E-E865-4A03-BD41-DBF4014539A9Q42369566-01DAD397-5502-4910-A2F4-7134CCB0B7B7Q43153020-A4EF9139-B1AE-4113-A0A2-45BC94F42CF9Q45298673-AF918620-23CA-4DD9-87D8-24F94AA4932CQ45304822-2E695932-BEE5-4BDB-B60D-E8C6BAED55F7Q45305901-798ED713-4953-490B-9445-DD9A93B9E8D7Q47154575-2A3C473F-C232-464B-BF2C-F77E22CE10D6Q48425350-652D3AE7-D00A-40CE-9815-AC343DA3D4D1Q48873303-55124BB4-5BDC-488A-84CB-B7ECA0B4699EQ50421506-DD2FB693-B319-48CC-AB85-495FD56DA663Q51744369-23D3ED3B-FAE4-4990-84F2-9C1CACAEFAB0Q51758698-7C27C3B4-83C0-4C13-8AF1-F510B6396549Q54943751-A53FA79C-B8CF-44B3-ADE9-A6F81AB3EFC9Q55259534-DFB52A2B-E900-48A4-A344-9E945F644F15Q55427881-B3F5ACDF-FAF0-4BA3-B105-6F656ABB62EFQ58780088-D3BF6209-7378-43F2-905B-A8FC1BD35D78
P2860
Huntington's disease and the striatal medium spiny neuron: cell-autonomous and non-cell-autonomous mechanisms of disease
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Huntington's disease and the s ...... tonomous mechanisms of disease
@en
Huntington's disease and the s ...... onomous mechanisms of disease.
@nl
type
label
Huntington's disease and the s ...... tonomous mechanisms of disease
@en
Huntington's disease and the s ...... onomous mechanisms of disease.
@nl
prefLabel
Huntington's disease and the s ...... tonomous mechanisms of disease
@en
Huntington's disease and the s ...... onomous mechanisms of disease.
@nl
P2860
P1433
P1476
Huntington's disease and the s ...... tonomous mechanisms of disease
@en
P2093
Michelle E Ehrlich
P2860
P2888
P304
P356
10.1007/S13311-012-0112-2
P577
2012-04-01T00:00:00Z